| (P1800) |
Verminderte Expression des atheroprotektiven Transkriptionsfaktors Krüppel-Like Factor 4 in zirkulierenden Monozyten-Subgruppen von Patienten mit koronarer Herzkrankheit |
|
F. S. Czepluch, H. Kuschicke, C. Dellas, J. Riggert, G. Hasenfuß, K. Schäfer (Göttingen) |
| (P1801) |
Freisetzungskinetik von microRNAs bei Patienten mit akutem Myokardinfarkt |
|
C. Liebetrau, O. Dörr, H. Möllmann, S. Szardien, L. Gaede, C. Troidl, S. Voss, J. Hoffmann, M. Willmer, J. Rixe, A. Rolf, C. W. Hamm, H. M. Nef (Bad Nauheim, Gießen) |
| (P1802) |
Myocardial Gremlin-1 expression serves as an additional biomarker in the risk assessment of patients with progressive systemic sclerosis and cardiac involvement |
|
K. A. L. Müller, T. Geisler, C. S. Zürn, K. Klingel, R. Kandolf, M. Röcken, M. Gawaz, I. I. Müller (Tübingen) |
| (P1803) |
Preconditioning of naïve endothelial cells with induction agents modulates the endothelial function in a time/dose dependent manner |
|
I. Kanzler, N. Bogert, F. Guo, U. Stock, A. Moritz, A. Beiras-Fernandez (Frankfurt am Main) |
| (P1804) |
The fusion protein mGremlin-1-Fc reduces significantly scar formation in mice after myocardial infarction and improves substantially left ventricular ejection fraction |
|
I. I. Müller, M. Schneider, T. Jürgens, T. Schönberger, M. Gawaz (Tübingen) |
| (P1805) |
Plasma ratio of Gremlin-1 and Macrophage Migration Inhibitory Factor indicates a higher risk for vulnerable plaque formation and acute coronary syndrome in patients with type 2 diabetes mellitus |
|
K. A. L. Müller, A. Karathanos, S. Breuning, M. Gawaz, T. Geisler, I. I. Müller (Tübingen) |
| (P1806) |
Gremlin-1 in patients with acute congestive heart failure |
|
M. Behnes, M. Brückmann, F. Espeter, S. Lang, P. Ahmad-Nejad, M. Neumaier, M. Borggrefe, U. Hoffmann (Mannheim, Ingelheim) |
| (P1807) |
Influence of reconstituted HDL (rHDL) on activation of platelet Gai- and Gq-protein coupled receptors |
|
U. Flierl, J. Bauersachs, A. Schäfer (Hannover) |
| (P1808) |
Impact of statin therapy on the occurrence of ventricular arrhythmias in ICD patients with coronary artery disease: do statins have antiarrhythmic properties? |
|
T. Kleemann, M. Strauß, A. Skarlos, K. Kouraki, R. Zahn (Ludwigshafen) |
| (P1809) |
Influence of high-dose highly efficient statins on short-term clinical outcome in patients undergoing percutaneous coronary interventions plus coronary stenting for acute coronary syndrome |
|
I. Tentzeris, M. Rohla, R. Jarai, S. Farhan, M. Freynhofer, G. Unger, A. Geppert, E. Wessely, M. Nürnberg, J. Wojta, K. Huber (Wien, AT) |
| (P1810) |
Stentimplantation in native Koronararterien versus Vena saphena-Bypass Grafts: Freisetzung von weniger partikulärem Material, aber mehr Endothelin |
|
P. Kleinbongard, T. Baars, S. Möhlenkamp, P. Kahlert, T. F. M. Konorza, R. Erbel, G. Heusch (Essen, Moers) |
| (P1811) |
Koronares Aspiratplasma von Patienten mit Vena-Saphena-Bypass-Stenose reduziert die koronare Mikrozirkulation und Ventrikelfunktion im Bioassay des isoliert perfundierten Rattenherzens. |
|
P. Kleinbongard, H. Lieder, P. Kahlert, T. F. M. Konorza, R. Erbel, G. Heusch (Essen) |